期刊档案 · Medicine-Medicine (miscellaneous)
Klinicheskaia praktika
ISSN 2220-3095 · eISSN 2618-8627 · Eco-vector · Russian Federation
Klinicheskaia praktika 钻石开放获取(无 APC),免版面费,出版商公布投稿到最终决定约 21 天,2025 年发文 39 篇,Scopus 收录。
研究范围
研究范围与定位
Klinicheskaia praktika 由 Eco-vector 出版。按 OpenAlex 近年发文统计,该刊主要发表 Legal and Regulatory Analysis、Linguistic, Cultural, and Literary Studies、Military Technology and Strategies 等主题的论文,这 3 个主题约占 66.7%。(根据 OpenAlex 主题统计与中科院分区数据生成)
The main idea of our journal is to provide description and analysis of clinical cases with severe, rare and difficult for diagnoses diseases, occurred in the clinics of Federal Medical-Biological Agency of Russia. Such clinical analysis is aimed to develop “clinical” type of thinking, always have been the characteristic feature of Russian/USSR medical school. The journal purpose is also to improve scientific discussions and cooperation between physicians of different specialties. Revival of historical traditions in our journal is the one of the components of continuing education, which is especially important in “closed” territories, where doctors can`t regularly participate in clinical conferences. An important aspect is to provide a printed tribune for any doctor who has an interesting clinical observation and wish to share his experience with colleagues. That is why we named our journal 'Journal of Clinical Practice' and address it, first of all, those skilled in applied medicine. Of course, we also publish the results of original researches, clinical guidelines, current reviews and medical news. The journal is multidisciplinary and we hope that it will be interesting to doctors of different specialties. The journal is published by means of the Federal Research and Clinical Center of FMBA of Russia. Publishing of all materials, except for advertising, are free of charge to authors.
摘自期刊官网 Aims & Scope
研究方向(LetPub):Medicine-Medicine (miscellaneous)
主编 Aleksandr V. Troitskiy出版商官网
编委会国家分布:中国大陆 3 位(约 5%);主要国家 俄罗斯 60、中国 3、匈牙利 1(共 64 位编委标注了国家) 编委会 ↗出版商官网 ·
主要研究主题 OpenAlex 近年发文统计,占比为近似值
- Legal and Regulatory AnalysisSocial Sciences22.3%
- Linguistic, Cultural, and Literary StudiesSocial Sciences22.2%
- Military Technology and StrategiesEngineering22.2%
- Healthcare Systems and Public HealthMedicine3.6%
- Long-Term Effects of COVID-19Medicine2.6%
- COVID-19 Clinical Research StudiesMedicine2.5%
- Neurological Disorders and TreatmentsNeuroscience2.2%
- Atrial Fibrillation Management and OutcomesMedicine1.7%
分区与收录
学科分区与数据库收录
中科院期刊分区表
期刊分区表( 2025年3月升级版)未收录
该期刊未被此版本分区表收录。
《新锐期刊分区表》( 2026年3月发布)未收录
该期刊未被此版本分区表收录。
期刊分区表( 2023年12月旧的升级版)未收录
该期刊未被此版本分区表收录。
数据库收录
ScopusDOAJLetPub
国际期刊预警名单:各版本均未列入LetPub
不同版本、大类与小类分别展示,不将不同评价口径合并为一个分区值;投稿与考核前请确认所在机构采用的版本。
指标
影响力指标与发文规模
影响力指标
- CiteScore 2026-06
- 0.4LetPub ·
- SJR 2026-06
- 0.12LetPub ·
- SNIP 2026-06
- 0.15LetPub ·
- h-index
- 12OpenAlex ·
- i10-index
- 18OpenAlex ·
- 两年平均被引
- 0.28OpenAlex ·
- Gold OA 文章占比
- 0%LetPub ·
逐年发文量 OpenAlex 统计 · 累计 1,096 篇 · 当年数据不完整
| 年份 | 发文量 | 其中 OA | 被引 |
|---|---|---|---|
| 2026 | 46 | 46 | 2 |
| 2025 | 39 | 39 | 11 |
| 2024 | 55 | 55 | 26 |
| 2023 | 50 | 50 | 36 |
| 2022 | 46 | 46 | 63 |
| 2021 | 81 | 81 | 147 |
不同来源的统计口径与观测时间不同,页面保留各来源原值;“出版商公布”为期刊官网自述数据。
审稿与录用
审稿周期与录用情况
出版商公布的审稿周期 期刊官网自述数据
21 天投稿到最终决定 · 投稿社区反馈约 12 周
出版商统计口径以官网为准;本刊近 24 个月的文章日期尚未获得,因此以官方数据为准。
各来源数据
- 平均审稿速度(社区反馈)
- 12 WeeksLetPub ·
- 投稿到最终决定
- 21 天出版商官网 ·
- 投稿到发表(期刊自报)
- 约 20 周DOAJ ·
- 评审方式
- 双盲同行评审DOAJ
社区反馈来自投稿者样本,置信度 0.5,不代表期刊承诺;“出版商公布”的时间节点定义以官网为准。
费用与开放获取
版面费与开放获取政策
所有文章开放获取,且不向作者收取文章处理费。
| 来源 | 文章处理费 | 费用减免 | 许可证 | 观测时间 |
|---|---|---|---|---|
| DOAJ | 无文章处理费 | 无 | CC BY-NC-ND | |
| LetPub | 无文章处理费 | 无 | — | |
| 出版商官网 | 无文章处理费 | — | — |
其他费用与减免(作者指南)
- 投稿费
- 无投稿费
- APC 费用说明 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
费用以期刊官网为准;不同来源的观测时间可能不同,页面保留各来源原值,不做平均。
投稿要求
文章类型与投稿政策(官网)
投稿准备要点4 项,摘自作者指南
- 正文篇幅
- ≤ 6,000 词
- 稿件模板
- 提供 Word 模板
- 首次投稿格式
- 允许不按期刊格式排版(free format)
- 投稿信(Cover letter)
- 必须提供
接收的文章类型3 种,含篇幅限制
- case reportbe even bigger. The full-text length of case reports or short communications should not exceed 4000 words. Correspondence and other non-research works should fa…正文 ≤ 4,000 词
- correspondencenications should not exceed 4000 words. Correspondence and other non-research works should fall within 1500 words. The Editorial Office may consider manuscripts…正文 ≤ 1,500 词
- reviewull Manuscript Length Original studies, reviews and study protocols should not exceed 6000 words, including tables, figures, author information, and referen正文 ≤ 6,000 词
官网政策摘录AI 使用、作者资格、利益冲突、数据可用性、出版伦理、许可与版权、开放获取、同行评审、查重、自存档
- AI 使用 V. Use of Artificial Intelligence
该期刊的编辑政策不限制作者将人工智能作为科研工具(方法)使用,但作者必须披露所用AI工具(软件、服务、平台)的名称、版本、开发者、来源(如适用,提供服务的通用URL)、使用流程、查询内容(包括其应用的顺序及其他细节)及查询日期(如适用),以及对准确性和完整性检查的结果。 模型中文摘要
In accordance with its editorial policy, the journal’s editorial board does not restrict authors use of AI as a tool (method) for scientific research. However, as with other research methods, authors must disclose information regarding the use of AI by describing the tool (software, service, platform), its version, developer, source (the general URL of the service, where applicable), the procedure…
原文 ↗出版商官网 ·- 作者资格 1) Author contributions
研究通常涉及多方参与,必须明确界定研究人员的角色,以便公平评估其贡献、确定其责任并防止署名纠纷或不公平的出版行为;请使用CRediT系统在稿件扉页上描述每位作者的贡献。 模型中文摘要
A research is a complex activity that usually involves multiple parties with different roles and levels of involvement in the research process. The roles of researchers must be clearly defined so that their contributions can be evaluated fairly, their responsibilities be determined, and disputes over authorship or unfair publishing practices be prevented. Please use the CRediT system (see here) to…
原文 ↗出版商官网 ·- 利益冲突 6) Disclosure of interests
所提交研究工作的任何资助(直接或间接的研究资助,包括成果发表)必须在Funding Sources部分注明;作者须在Disclosure of Interests部分声明其与可能受文章内容影响的利益相关方(营利或非营利第三方、个人)是否存在关系,并声明过去三年内有无相关关系、活动或利益。 模型中文摘要
Any funding of the submitted research work (direct or indirect research funding, including publication of the results) must be specified in the Funding Sources section. In the Disclosure of Interests section, the authors declare that they have or have no relationships with any stakeholders (for-profit or not-for-profit third parties, physical individuals) whose interests may be affected by the con…
原文 ↗出版商官网 ·- 数据可用性 8) Data availability statement
数据指研究中使用(第三方数据)或获得(收集或创建)的任何信息;作者必须在方法部分或其他适合描述研究方法的部分以及原创性声明部分报告使用已发表的第一方或第三方数据的情况,并说明文章和/或补充材料是否呈现研究中获得的全部数据(常见于综述和病例报告)。 模型中文摘要
Data refers to any information used (third-party data) or obtained (collected or created) in a study. The authors must report the use of previously published first- or third-party data in the Methods section or other section appropriate for describing the research methodology, as well as in the Statement of originality section. Specify whether the article and/or its supplements present all the dat…
原文 ↗出版商官网 ·- 出版伦理
如果发现作者故意提交不准确的信息,期刊保留中止审稿流程或撤回已发表文章的权利。 模型中文摘要
The journal reserves the right to discontinue the review process or retract the published article if the authors are found to have intentionally submitted inaccurate information.
原文 ↗出版商官网 ·- 许可与版权 Copyright Notice
作者仅在文章被接受发表后将文章版权转让给出版商;作者可依据期刊的自存档政策使用和分发文章;文章仅能由主编和编委会依据稿件遴选政策决定接受发表。 模型中文摘要
Authors who publish with this journal agree to the following terms: Authors transfer article copyright to the publisher only after the acceptance to publication.Authors are able to use and distribute the article in accordance with Self-Archiving policy of the journal.The article can be accepted for publication only by decision of the Editor-in-Chief and the Editorial board of the journal in accord…
原文 ↗出版商官网 ·- 开放获取 Open Access Policy
该期刊提供即时开放获取,出版商通过开放许可(Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International)授予使用权利,允许用户免费阅读、下载、复制、分发、打印、检索、链接全文或将其用于其他合法用途。 模型中文摘要
This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge. The Publisher grants usage rights to others using an open license (Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International) allowing for immediate free access to the work and permitting any user to read, …
原文 ↗出版商官网 ·- 同行评审 10) Provenance and peer-review
期刊文章可为自发投稿或约稿,可经快速通道或标准流程评审,并由独立专家及其他利益相关方(包括与编辑部有关联者)同行评审;作者须在投稿时披露稿件来源(自发投稿或约稿)。 模型中文摘要
Articles published in the journal may be submitted unsolicited or commissioned by the journal; be reviewed following the fast-track or standard procedure; and be peer-reviewed by independent experts and other stakeholders, including those associated with the Editorial Office. To ensure transparency and properly inform readers, please disclose the origin of the manuscript upon submission (whether i…
原文 ↗出版商官网 ·- 查重 Plagiarism
任何形式的剽窃均属不道德的出版行为,不可接受;该期刊只接受原创作品,不允许任何形式的剽窃,作者不得不加引用地使用他人的文字、图表或观点,所有来源必须在文中引用。 模型中文摘要
Plagiarism takes many forms, from passing off another paper as the author(s) own paper, to copying or paraphrasing substantial parts of another(s) paper (without attribution), to claiming results from research conducted by others. Plagiarism in all its forms constitutes unethical publishing behavior and is unacceptable. Only original works are acceptable for publication in 'Journal of Clinical Pra…
原文 ↗出版商官网 ·- 自存档 Author Self-Archiving
该期刊遵循白金开放获取模式进行文章传播,包括开放自存档政策;相关术语定义包括:预印本(投稿前的早期版本,学位论文视为预印本)、审稿中稿件(SMUR,正在正式评审的版本)、已接受稿件(AM,已被接受发表的版本,可能包含修改)。 模型中文摘要
The journal is compliant with Platinum Open Access mode for articles distribution that includes Open Self-Archiving policy. Terms and definitionsWe use the following terms and definitions:Preprint: An early version of an article prior to the version submitted for publication in a journal. Theses and dissertations are considered to be preprints.SMUR (Submitted Manuscript Under Review): The version …
原文 ↗出版商官网 ·
摘录来自期刊官网页面,仅保留原文片段;“模型摘要”由 Workers AI 生成并经原文校验,以官网为准。
基本信息
出版信息与官方入口
- 出版商
- Eco-vector
- 出版国家或地区
- Russian Federation
- 出版语言
- Russian
- ISSN
- 2220-3095
- 电子版 ISSN
- 2618-8627
- 官网最新一期
- Volume 17, Issue 2(2026 年)
- 官方链接
- 期刊主页 ↗LetPub
- 作者指南 ↗LetPub
- Aims & Scope ↗LetPub
- APC 费用说明 ↗DOAJ
- 开放获取声明 ↗DOAJ
- 许可与版权 ↗DOAJ
- 评审流程 ↗LetPub
- 编委会 ↗LetPub
- 查重政策 ↗DOAJ
常见问题
关于 Klinicheskaia praktika 的常见问题
Klinicheskaia praktika 的审稿周期多长?
出版商公布的投稿到最终决定时间约为 21 天;投稿社区反馈的平均审稿速度为约 12 周。文章统计只含被录用的稿件,出版商数据口径以官网为准,社区反馈来自投稿者样本,均不代表期刊承诺。
Klinicheskaia praktika 的投稿格式要求是什么?
据期刊作者指南:正文篇幅:≤ 6,000 词;稿件模板:提供 Word 模板;首次投稿格式:允许不按期刊格式排版(free format);投稿信:必须提供。以上由模型从作者指南提取并逐项与原文核对,投稿前请以官网最新版本为准。
Klinicheskaia praktika 的编委会里有中国学者吗?
期刊官网编委会页面上标注了国家的 64 位编委中,中国大陆 3 位(约 5%);人数最多的国家是 俄罗斯(60 位)、中国(3 位)、匈牙利(1 位)。统计按编委会页面列出的机构国家计,仅供参考。
Klinicheskaia praktika 被哪些数据库收录?
据 LetPub 与 DOAJ 记录,Klinicheskaia praktika 被 Scopus、DOAJ 收录。
Klinicheskaia praktika 是开放获取期刊吗?版面费多少?
Klinicheskaia praktika 为钻石开放获取(无 APC)。不收取文章处理费。
来源与更新
本页事实来自 LetPub、OpenAlex、出版商官网、DOAJ;每个数字旁标注来源与观测日期,冲突数据保留各来源原值。LetPub 原始详情页:查看 ↗(2026-08-25 归档)。最近更新:。